Safety and Immunogenicity of the ChAdox1 nCoV-19 (AZD1222) Vaccine Against SARS-CoV-2 in HIV Infection (2021)

First Author: Frater J
Attributed to:  Natural Killer Cells as Effectors in HIV Cure Strategies funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2139/ssrn.3829931

Publication URI: http://dx.doi.org/10.2139/ssrn.3829931

Type: Journal Article/Review

Parent Publication: SSRN Electronic Journal